- Home
- CISS vs BJDX Comparison
CISS vs BJDX Comparison
Compare CISS & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CISS | BJDX |
|---|---|---|
| Founded | 2022 | 2015 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9M | 1.8M |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CISS | BJDX |
|---|---|---|
| Price | $2.08 | $4.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.3M | ★ 2.2M |
| Earning Date | 05-19-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 86.65 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $249,040.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.82 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.08 | $0.63 |
| 52 Week High | $6.06 | $7.00 |
Technical Indicators
Market Signals| Indicator | CISS | BJDX |
|---|---|---|
| Relative Strength Index (RSI) | 43.18 | 70.46 |
| Support Level | $2.00 | $1.46 |
| Resistance Level | $2.23 | $7.00 |
| Average True Range (ATR) | 0.23 | 0.80 |
| MACD | -0.05 | 0.17 |
| Stochastic Oscillator | 38.82 | 58.95 |
Price Performance
Historical ComparisonAbout CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of its fleet is approximately 64,000 dwt.
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.